Invitation to Senzime’s investor event

Senzime AB (publ) invites investors, financial analysts and media to a digital investor event on November 15, 2022, in the afternoon.

The purpose is to give an update of the strategy following the acquisition of Respiratory Motion, describe the market opportunities following the upcoming clinical guidelines in the US and Europe that support Senzime’s solutions, and provide long-term financial targets.

Presentations will be held by:

  • Pia Renaudin, CEO of Senzime
  • Sorin J. Brull, Professor, board member of Senzime AB and the innovator of TetraGraph
  • Kay Krüger, business manager of the recently acquired ExSpiron business who will present the latest updates on market development in Europe and the US

Presentations will be held in English and followed by a Q&A session.

Date and time
Tuesday November 15, 2022, at 13:00-15:00 CET.

More information and a link to the event will be shared in the beginning of November.

Contact us

Want to know more?

How can Senzime’s innovative patient monitoring solutions help to eliminate in-hospital complications?
Contact us today.